• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Devon Park BioVentures

edit

Devon Park Bioventures is a venture capital fund targeting investments in therapeutics companies and, in certain cases, medical device, diagnostic and drug discovery technology companies.

Recent Milestones

edit

• 
  Devon Park BioVentures invested in ZS Pharma. (10/23/12)
  Posted 10/25/12 at 7:16pm via bizjournals.com
• 
  Devon Park BioVentures invested in Vascular Magnetics. (2/22/12)
  Posted 2/22/12 at 7:20pm via fiercebiotech.com
• 
  Devon Park BioVentures invested in Cara Therapeutics. (7/21/10)
  Posted 7/21/10 at 6:59pm via fiercebiotech.com
• 
  Devon Park BioVentures invested in Inotek Pharmaceuticals. (6/11/10)
  Posted 6/13/10 at 7:56pm via fiercebiotech.com
• 
  Devon Park BioVentures invested in Cempra . (6/2/09)
  Posted 6/17/09 at 10:44am via onbiovc.com
• 
  Devon Park BioVentures invested in Proteon Therapeutics. (5/28/09)
  Posted 6/17/09 at 12:20pm via proteontherapeutics.com

Investments

Videos

Sources

1. ZS Pharma lands $46 million for kidney and liver drug development (bizjournals.com) [edit]
2. Venture backer makes $7M bet on cardio drug tech that could rival stents (fiercebiotech.com) [edit]
3. Cara rounds up $15M for post-op pain drug Read more: Cara rounds up $15M for post-op pain drug (fiercebiotech.com) [edit]
4. Inotek gathers $18M as it plots PhII trials Read more: Inotek gathers $18M as it plots PhII trials (fiercebiotech.com) [edit]
5. Cempra Pharmaceuticals, Inc.: Series C $46M (onbiovc.com) [edit]
6. Proteon Therapeutics Completes Second Closing of Equity Financing (proteontherapeutics.com) [edit]